04.23.09

The Next Cancer Bestseller?

Posted in Uncategorized at 7:40 pm by hope

Novartis has ambitious plans for its new kidney cancer drug.

Permalink Comments off

Posted in Uncategorized at 8:01 pm by hope

This year, pharmaceuticals could see the worst sales growth of the past quarter century.

Permalink Comments off

Posted in Uncategorized at 4:40 pm by hope

Roche overpaid for Genentech. The question is by how much.

Permalink Comments off

Posted in Uncategorized at 2:25 pm by hope

Quarterly numbers show why Merck decided, after years of merger aversion, to buy Schering-Plough.

Permalink Comments off

Posted in Uncategorized at 4:32 pm by hope

A victory for the company's controversial prostate cancer treatment, but more debate lies ahead.

Permalink Comments off